CRISPR Therapeutics (CRSP) Q1 2026 Earnings

17FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-2.4
-1.99
-1.58
-1.16

Details

Expected EPS
-1.162892
Actual EPS
N/A
Surprise EPS
1.16
Surprise Percent
+100%

Description

CRISPR Therapeutics (CRSP) will report earnings of for Q1 2026 on February 17, 2026.

0 Comments

Share your thoughts